News & Updates

Show Multimedia Only
ART discontinuation tied to toxicity, disease progression in mCRPC patients
ART discontinuation tied to toxicity, disease progression in mCRPC patients
07 Jun 2024

Several patients with metastatic castration-resistant prostate cancer (mCRPC) discontinue the use of androgen receptor‒targeted therapies (ARTs) because of disease progression, while a few stopped ARTs due to treatment toxicity, according to a study.

ART discontinuation tied to toxicity, disease progression in mCRPC patients
07 Jun 2024
COVID-19 does mess with the brain even years after infection
COVID-19 does mess with the brain even years after infection
06 Jun 2024 byAudrey Abella

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

COVID-19 does mess with the brain even years after infection
06 Jun 2024